ADC Therapeutics SA Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.59 | -$0.52 | -$0.56 |
| Q2 2024 | 1 | -$0.49 | -$0.43 | -$0.46 |
| Q3 2024 | 3 | -$0.42 | -$0.37 | -$0.40 |
| Q4 2024 | 5 | -$0.49 | -$0.36 | -$0.43 |
| Q1 2025 | 2 | -$0.49 | -$0.45 | -$0.48 |
| Q2 2025 | 1 | -$0.52 | -$0.46 | -$0.49 |
| Q3 2025 | 1 | -$0.49 | -$0.43 | -$0.46 |
| Q4 2025 | 1 | -$0.49 | -$0.43 | -$0.46 |
ADC Therapeutics SA Earnings Date And Information
ADC Therapeutics SA last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.42 earnings per share for the quarter, missing analysts' consensus estimates of $-0.39 by $0.03. The company had revenue of 18.02 M for the quarter and had revenue of 69.56 M for the year. ADC Therapeutics SA has generated $-3 earnings per share over the last year ($-2.94 diluted earnings per share) and currently has a price-to-earnings ratio of -0.98. ADC Therapeutics SA has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based on prior year's report dates.
ADC Therapeutics SA Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.39 | -$0.42 | -0.03 | $18.43 M | $18.02 M |
| 08/06/2024 | Q2 2024 | -$0.44 | -$0.38 | 0.06 | $18.89 M | $17.41 M |
| 05/06/2024 | Q1 2024 | -$0.56 | -$0.56 | 0 | $18.05 M | |
| 03/13/2024 | Q4 2023 | -$0.47 | -$1.03 | -0.56 | $16.79 M | |
| 11/07/2023 | Q3 2023 | -$0.61 | -$0.58 | 0.03 | $15.15 M | $14.49 M |
| 08/08/2023 | Q2 2023 | -$0.44 | -$0.58 | -0.14 | $20.25 M | $19.28 M |
| 05/09/2023 | Q1 2023 | -$0.80 | -$0.74 | 0.06 | $18.99 M | |
| 03/15/2023 | Q4 2022 | -$0.30 | $69.80 M | |||
| 11/08/2022 | Q3 2022 | -$0.51 | -$0.65 | -0.14 | $60.70 M | $76.32 M |
| 05/09/2022 | Q2 2022 | -$0.76 | -$0.84 | -0.08 | $31.22 M | $17.29 M |
| 05/09/2022 | Q1 2022 | -$0.76 | -$0.22 | 0.54 | $46.50 M | |
| 03/17/2022 | Q4 2021 | -$0.45 | $17.01 M | |||
| 11/02/2021 | Q3 2021 | -$0.97 | -$0.93 | 0.04 | $7.39 M | $13.15 M |
| 05/06/2021 | Q2 2021 | -$1.00 | -$0.95 | 0.05 | $2.23 M | $3.76 M |
| 05/06/2021 | Q1 2021 | -$1.00 | -$0.67 | 0.33 | $0 | |
| 11/12/2020 | Q4 2020 | -$0.77 | -$0.73 | 0.04 | $51.90 M | |
| 08/18/2020 | Q3 2020 | -$0.76 | -$0.29 | 0.47 | $42,667 | $0 |
| 08/18/2020 | Q2 2020 | -$0.76 | -$2.01 | -1.25 | $599,000 | $0 |
| 03/31/2020 | Q1 2020 | -$0.68 | $0 | |||
| 12/31/2019 | Q4 2019 | -$0.48 | $0 |
ADC Therapeutics SA Earnings: Frequently Asked Questions
-
When is ADC Therapeutics SA's earnings date?
ADC Therapeutics SA has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates.
-
How can I listen to ADC Therapeutics SA's earnings conference call?
The conference call for ADC Therapeutics SA's latest earnings report can be listened to online.
-
How can I read ADC Therapeutics SA's conference call transcript?
The conference call transcript for ADC Therapeutics SA's latest earnings report can be read online.
-
How much revenue does ADC Therapeutics SA generate each year?
ADC Therapeutics SA (:ADCT) has a recorded annual revenue of $69.56 M.
-
How much profit does ADC Therapeutics SA generate each year?
ADC Therapeutics SA (:ADCT) has a recorded net income of $69.56 M. ADC Therapeutics SA has generated $-2.94 earnings per share over the last four quarters.
-
What is ADC Therapeutics SA's price-to-earnings ratio?
ADC Therapeutics SA (:ADCT) has a price-to-earnings ratio of -0.98 and price/earnings-to-growth ratio is -0.16.
